{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04965",
    "Peptide Name": "LM2 (Lactomodulin fragment, Gly-rich, Synthetic AMPs, XXA, UCLL1c)",
    "Source": "sequence truncation, bacteria-derived, natural derivatives",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "SGGIGPLVIP",
    "Sequence Length": 10,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 1,
    "Boman Index": -1.82,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "40%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (45.45%) toPeptide fraction IIG: 30%, I=P: 20%.Activity: active against S. aureus ATCC 25923 (MIC 2.1 uM), MRSA BAA 2313 (NA), C. difficile ATCC 43602 (MIC 1.6 uM), L. monocytogenes ATCC 15313 (MIC 1.2 uM), E.faecium VRE BAA 2317 (NA), E. coli ATCC 33694 (MIC 8.9 uM), P. aeruginosa BAA 1744 (MIC 9.5 uM), and S.enterica ATCC 13314 (NA). NA: not observed.",
    "Author": "Mousa WK, Shaikh AY, Ghemrawi R, Aldulaimi M, Al Ali A, Sammani N, Khair M, Helal MI, Al-Marzooq F, Oueis E. 2024",
    "Reference": "RSC Med Chem. 2024 Oct 28. doi: 10.1039/d4md00383g.PubMed",
    "Title": "Human microbiome derived synthetic antimicrobial peptides with activity against Gram-negative, Gram-positive, and antibiotic resistant bacteria."
  },
  "3D Structure": []
}